Back to results
US 7,402,601 B2Granted
Pharmaceuticals for the treatment of rejection reactions in organ transplantations
AssigneeSanofi-Aventis Deutschland GmbH
InventorRobert Ryder Bartlett
Life of this patent
Estimating the term…
Abstract
The use of compound 1 and/or 2 of the formulae and of physiologically tolerable salts of compound 2 for the treatment of rejection reactions of the organ recipient to the transplanted organ is described.
Claims2
A method of treating a hyperacute rejection reaction of a xenograft transplant recipient of a xenograft transplant, which comprises administering to said recipient an effective amount of a composition comprising at least one compound chosen from (a) a compound of formula 1 and (b) a compound of formula 2 and its physiologically tolerable salts:
Dependencies are inferred from the claim text.